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Peripheral nerve injury alters the expression of hundreds of proteins in dorsal root ganglia
(DRG). Targeting some of these proteins has led to successful treatments for acute pain,
but not for sustained post-operative neuropathic pain. The latter may require targeting
multiple proteins. Since a single microRNA (miR) can affect the expression of multiple
proteins, here, we describe an approach to identify chronic neuropathic pain-relevant
miRs. We used two variants of the spared nerve injury (SNI): Sural-SNI and Tibial-SNI and
found distinct pain phenotypes between the two. Both models induced strong mechanical
allodynia, but only Sural-SNI rats maintained strong mechanical and cold allodynia, as
previously reported. In contrast, we found that Tibial-SNI rats recovered from mechanical
allodynia and never developed cold allodynia. Since both models involve nerve injury, we
increased the probability of identifying differentially regulated miRs that correlated with
the quality and magnitude of neuropathic pain and decreased the probability of detecting
miRs that are solely involved in neuronal regeneration. We found seven such miRs in
L3-L5 DRG. The expression of these miRs increased in Tibial-SNI. These miRs displayed
a lower level of expression in Sural-SNI, with four having levels lower than those in sham
animals. Bioinformatic analysis of how these miRs could affect the expression of some ion
channels supports the view that, following a peripheral nerve injury, the increase of the
seven miRs may contribute to the recovery from neuropathic pain while the decrease
of four of them may contribute to the development of chronic neuropathic pain. The
approach used resulted in the identification of a small number of potentially neuropathic
pain relevant miRs. Additional studies are required to investigate whether manipulating the
expression of the identified miRs in primary sensory neurons can prevent or ameliorate
chronic neuropathic pain following peripheral nerve injuries.
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INTRODUCTION
Surgical procedures are often associated with chronic neuropathic
pain (Macrae, 2001). Despite the introduction of improved surgi-
cal procedures, about 10–50% of patients develop chronic pain
and 2–10% of patients develop severe disabling chronic pain
(Nathan and Pappas, 2003; Kehlet et al., 2006; Pokorny et al.,
2008; Vadivelu et al., 2008; Gahm et al., 2010). While the intensity
of acute post-operative pain is a good predictor of long-term pain,
adequate control of acute post-operative pain does not always
prevent the development of chronic pain (Perkins and Kehlet,
2000).
The primary sensory neurons are the first neurons in the sen-
sory pathway to be directly affected following peripheral nerve
injury. The injury-evoked changes include alterations in neuro-
transmitter release, expression of channels and receptors, which
contribute to neuronal hyperexcitability and ectopic discharges.
These peripheral changes initiate a cascade of events in the cen-
tral nervous system leading to a decrease in inhibitory control
and increase in sensitivity that eventually result in chronic neu-
ropathic pain (Wall and Gutnick, 1974a,b; Wall and Devor, 1983;
Tal and Eliav, 1996; Ali et al., 1999; Liu et al., 1999, 2000a,b;
Woolf and Mannion, 1999; Wu et al., 2001, 2002; Gold et al.,
2003). Many studies have focused on discerning which of the
injury-evoked changes in primary sensory neurons contribute to
the development of chronic pain. Peripheral nerve injury alters
the expression of hundreds of proteins in the dorsal root gan-
glia (DRG) where the somata of primary sensory neurons are
located (Hokfelt et al., 1994; Araki et al., 2001; Bonilla et al., 2002;
Costigan et al., 2002; Wang et al., 2002; Xiao et al., 2002; Jimenez
et al., 2005; Nilsson et al., 2005; Komori et al., 2007; Stam et al.,
2007; Persson et al., 2009a). Some of these changes appear to con-
tribute to the development of neuropathic pain (Persson et al.,
2009a; Berger et al., 2011; Xu and Yaksh, 2011). This informa-
tion has led to successful treatments for acute pain, which usually
involve the targeting of several molecules, but sadly effective
chronic neuropathic pain treatment still remains elusive. Since
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nerve injury evokes global increases in gene expression (Araki
et al., 2001; Bonilla et al., 2002; Costigan et al., 2002; Wang et al.,
2002; Xiao et al., 2002; Jimenez et al., 2005; Nilsson et al., 2005;
Komori et al., 2007; Stam et al., 2007), treatment of chronic neu-
ropathic pain may require the simultaneous alteration of multiple
proteins. One approach that has been investigated is to produce a
general block of protein synthesis; while this approach has shown
encouraging results in animal models (Melemedjian et al., 2011)
it has limitations in clinical settings because ongoing protein syn-
thesis is required for normal cell function as well as functional
recovery following an injury. Another approach is to manipu-
late the expression of microRNAs (miRs). miRs are small (∼22
nucleotides) non-coding RNAs that regulate gene expression by
interacting with sites in the 3′ untranslated regions of mRNA
molecules to inhibit translation of proteins (Lewis et al., 2005;
Chen and Rajewsky, 2007). Since its interaction with mRNA does
not require a full complementary sequence, a single miR can tar-
get hundreds of distinct mRNA (Lewis et al., 2005). A change
in just one miR could theoretically coordinate multiple protein
changes that lead to the development of peripheral nerve-injury
induced chronic pain. Because of this, there is a recent growing
interest in understanding the roles of miRs in pain (Niederberger
et al., 2011). The capacity of miRs to affect the translation of
multiple pain-relevant proteins make them potential targets for
therapeutic intervention to prevent or treat chronic neuropathic
pain following peripheral nerve injuries induced by surgery or
trauma. Alterations in a large number of miRs expressed both in
the DRG and in the nerve stump have been reported in various
sciatic nerve injury models (Strickland et al., 2011; von Schack
et al., 2011; Yu et al., 2011b; Zhang et al., 2011; Zhou et al.,
2011) and in cancer and inflammatory models (Sakai and Suzuki,
2014) of chronic pain. The down-regulation of some of these
miRs has been linked to the up-regulation of proteins in the
pro-nociceptive machinery (von Schack et al., 2011). Differential
expression of mRNAs (Persson et al., 2009a) and miRs (Bali et al.,
2014) in DRG have also been postulated to contribute to pain
predisposition following spinal nerve injury.
In this study we first describe the simultaneous use of Sural-
SNI and Tibial-SNI in adult rats to facilitate the identification of
molecular changes that are pain relevant. Using this approach we
identified seven miRs that were differentially regulated in DRG.
Finally, based on the predicted targets of these miRs, we discuss
how their differential expression could be contributing to either
the transition from acute to chronic pain in the Sural-SNI model
or to the recovery from acute pain in the Tibial-SNI model.
MATERIALS AND METHODS
ANIMAL MODEL
Adult male Sprague–Dawley rats (250–300 g) were used follow-
ing the guidelines approved by the New York University Langone
Medical Center Institutional Animal Care and Use Committee.
Under isoflurane anesthesia, the spared-nerve injury (SNI) was
performed as previously described (Decosterd and Woolf, 2000).
We used two different variations of the SNI: the Sural-SNI that
consisted in the ligation and cutting of the common peroneal and
the tibial nerve branches and the Tibial-SNI that consisted in the
ligation and cutting of the common peroneal and the sural nerve
branches. The ligated branches were transected distal to the liga-
ture, and 2–3mmof each distal nerve branch stumpwas removed.
In sham controls, the sciatic nerve and its branches were exposed
but none of the branches were ligated or transected.
BEHAVIORAL TEST
Mechanical allodynia was evaluated in individual rats placed in
plexiglass boxes upon an elevated metal grid allowing access to
the plantar surface of the hind-paws. Mechanical thresholds were
measured in the plantar surface of the hind-paws ipsilateral and
contralateral to the injury with an electronic von Frey apparatus
equipped with a size 15 filament fitted on the 800 gram arm (IITC
Life Sciences, Inc.). Cold allodynia was assessed on the plantar
surface of the hind-paws by placing 20μl of absolute acetone with
an eppendorf multistepper pipette and measuring the duration
of paw withdrawal in the 30 s immediately following the ace-
tone application. As a control, we also applied 20μl of water at
37◦C before and after the acetone test. Water did not induce a
withdrawal response. For each day, mechanical and cold allody-
nia measurements were repeated three times with an interval of
about 5min between stimuli, and for each animal the mean value
was used. Rats were “marked” on the top of their tails and were
randomly placed into the individual plexiglass boxes. The inves-
tigator doing the measurements could not see the “mark” on the
rat’s tail. Mechanical thresholds were measured in both the Tibial
and Sural areas in all the animals. The person applying the fil-
ament was different from the person doing the read out on the
electronic von Frey apparatus.
LUMBAR DRG COLLECTION
Under isoflurane anesthesia a transcardial perfusion was per-
formed using cold oxygenated artificial cerebro spinal fluid
(ACSF) (in nM: Dextran 0.4, Sucrose 125, Glycerol 125, NaHCO3
26, Glucose 15, Hepes 2.1, KCl 3, MgSO4 1.3, KH2PO4 1.2; pH
7.4). This was done to cool down the tissues prior to isolation to
decrease RNA degradation/processing and to decrease the contri-
bution of blood-derived (plasma and cells) miRs. The rats were
then decapitated and their DRG (L3-L5) collected, the DRG’s
roots removed. Immediately after isolation the DRG were placed
in RNAlater stabilization Reagent (Qiagen, cat#1017980) at 4◦C
for 24 h and subsequently stored at −20◦C.
Total RNA EXTRACTION FROM SINGLE DRG
Since the amount of our starting material is very small
(1–2mg) we used a strategy described in the miRNeasy mini
Handbook “for purification of total RNA, including miRNA”
p. 24 (https://www.dkfz.de/gpcf/fileadmin/downloads/miRNA/
Qiagen_miRNeasy_Mini_Handbook.pdf). To inactivate RNAses,
the DRG were disrupted using 700μl of Phenol/guanidine-based
QlAzol Lysis reagent (Qiagen, cat#79306) and an automatic
cordless motor pestle mixer (cat#K749540-000, Kimble Chanse
Kontes). The lysate was then passed through a QlAshredder
column (Qiagen, cat#79654). The extraction of total RNA was
done by using a phase separation with chloroform. Chloroform
(140μl) was added to the homogenate and the organic and aque-
ous phases were separated through centrifugation (12,000 g, for
15min at 4◦C). The aqueous upper phase containing RNA was
Frontiers in Neuroscience | Neurodegeneration August 2014 | Volume 8 | Article 266 | 2
Norcini et al. microRNAs and peripheral nerve injury
collected and 1.5 × Volume of 100% absolute ethanol was added.
It was then passed through an RNeasy Min Elute Spin Colum
(that comes within the RNeasy PlusMicro Kit, Qiagen, cat#74034;
no other components of the kit were used); and washed one time
with 700μl of RTW buffer and twice with 500μl of RPE buffer
(Total RNA was then eluted from the column with 14–20μl of
RNase free water. The concentration of total RNA was obtained
by using a Thermoscientific NanoDrop 2000 Spectrophotometer.
The integrity of the samples was evaluated using the Agilent 2100
Bioanalyzer. The Nanodrop and Bioanalyzer measurements were
carried out by the NYU Langone Genome Technology Center
(NIH/NCI P30CA016087). The RNA integrity number (RIN) of
our samples ranged between 7.3 and 9.
MICROARRAY ANALYSIS
We used TaqMan Rodent Array Micro RNA Card-Av 2
(cat#4398967, Applied Biosystems, Life Technologies) in a
7900HT instrument from Applied Biosystems following the com-
pany indications (http://tools.lifetechnologies.com/content/sfs/
manuals/4399721c.pdf) and performed by the NYU Langone
Genome Technology Center. Briefly the probes used were labeled
with FAM™ dye linked to their 5′ end. The probes also contained
an nonfluorescent quencher (NFQ) at their 3′ end. “When the
oligonucleotide probe is intact, the proximity of the quencher
dye to the reported dye causes the reported dye signal to be
quenched.” Forty cycles of amplification were done, no cut-off
value was used. For analysis only miRs that were detected in the
12 samples (12 arrays) were used (Supplement 1). This card con-
tains 384 TaqMan® MicroRNA Assays that enables quantitation
of 335 and 226 miRs for mouse and rat, respectively. Many of the
mature miRs are identical between mouse and rats. MammU6-
4395470, snoRNA135-4380912 and U87-4386735 were used as
the reference miRs to obtain CT values for each of the miRs
in each of the samples by using ExpressionSuite Software v1.0.3
(Applied Biosystems) and exported to an excel file. In the excel
file, the “Sham CT” values (the control sample) was used to
obtain the “fold change” (2−CT) of each miR in the exper-
imental groups (Sural-SNI and Tibial-SNI). This was done by
subtracting the values between the corresponding DRG (e.g., “L3-
DRG-Sural-SNI CT” minus “L3-DRG-Sham CT,” “L4-DRG-
Sural-SNI CT” minus “L4-DRG-Sham CT” etc.) (Schmittgen
and Livak, 2008). There was no outlier exclusion used. To more
easily visualize the decreases vs. the increases in expression, the
data were presented as “log2 (fold change).” The data from Tibial-
SNI and Sural-SNI were compared using one-tailed unpaired
t-test (Prism, GraphPad Software, Inc.), differences with P val-
ues less than P = 0.09 were considered significant and the actual
P values are given in figure legends. The microarray data were
deposited to GEO (http://www.ncbi.nlm.nih.gov/geo/query/acc.
cgi?acc=GSE60033).
REVERSE TRANSCRIPTION (RT) AND QUANTITATIVE PCR (qPCR) OF
SELECTED miRs
Stem-loop RT primers and primers to do the correspond-
ing qPCR for the following miRs: miR-1-3p, (ID#002064),
miR-130a-3p (ID#000454), miR-133b-3p (ID#002247), miR-
143-3p (ID#000466), miR-145-5p (ID#002278), miR-193b-3p
(ID#002467), miR-191a-5p (ID#002299), miR-325-3p
(ID#002510), miR-335 (ID#000546), U6 snRNA (ID#001973),
U87 (ID#001712) and snoRNA135 ID#001230) were pur-
chased from Applied Biosystems (TaqMan microRNA Assays
cat#PN4427975). According to the company these primers are the
same ones as those used in the TagMan Rodent Array MicroRNA
Card Av 2 that we used for the initial microarray analysis. A
multiplex RT primer pool was done by mixing 10μl from each
of the 12 individual 5X RT stem-loop primers with 880μl of
1XTE buffer. The RT step was done using the TaqManMicroRNA
Reverse Transcription Kit (Applied Biosystems, cat# 4366596)
in an Eppendorf Mastercycler ep Gradient S with a ramp speed
of 2.3◦C/s. For each tube the total reaction volume was 15μl,
which included 6μl of RT stem-loop primer pool, 3μl of total
RNA (350–500 ng for reaction). A water control (3μl of water)
was also run to check the background related with the multiplex
of RT stem loop primers. All reactions were run in duplicate
The thermal-cycling conditions used were those suggested by the
company (30min at 16◦C, 30min at 42◦C, 5min at 85◦C and
hold at 4◦C at the end).
TargetScan (http://www.targetscan.org/vert_50/) andMiranda
(http://www.microrna.org/microrna/getMirnaForm.do) soft-
ware were used to identify potential mRNA targets for the
identified miRs. The list of potential mRNA targets was
filtered by selecting those that encode for various ion chan-
nels, and are known to be important for normal neuronal
excitability.
LABELING OF INJURED NEURONS
2–3 crystals (diameter 0.1–0.5mm) of the tracer DiI (1,1′-
dioctadecyl3,3,3′,3′-tetramethylindocarbocyanin-perchlorate)
were placed on the stump of the transected branches (30min) to
allow for tracer uptake. Gelfoam was used to support the stumps
(of the injured branches), to hold the crystals in place, and to
cover the spared (uninjured) nerve branch. Following 30min,
Gelfoam and whatever was left of the crystals were removed.
DRG were collected at day 86 post-surgery and sections were
obtained as previously described (Castillo et al., 2013). Neuronal
somata were visualized by staining the slices with Nissl #N21480
(1:100; Invitrogen Molecular Probes) (20min, RT) according to
the manufacturer’s protocol. Dil and Nissl labeling was visualized
by using Images captured with a ZeissAxiovert 200 (Germany)
inverted microscope equipped with fluorescence and Nomarski
optics, objective 10×.
INTER-DIGITAL DISTANCE
Animals were held such that the hind limbs were left undis-
turbed and allowed to move freely. The distance between
digit 1 and 5 was measured. For each group of animals,
the values were normalized to the value observed in the
Sham-CL paw.
STATISTICAL ANALYSIS
To compare more than two groups we used One-Way ANOVA,
followed by a Bonferroni’s Multiple comparison Post-test. To
compare only two groups, we used Unpaired t-test, one-tailed.
These tests were done using the Prism 5.0.4 for Windows
(GraphPad Software, Inc.).
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RESULTS
DIFFERENT PATTERNS OF MECHANICAL- AND COLD-ALLODYNIA IN
SURAL- AND TIBIAL SNI
We selected two modalities of the spared nerve injury (SNI) of
the sciatic nerve, the Sural-SNI and the Tibial-SNI. In the two
SNI variants, the onset of mechanical allodynia and its high-
est allodynia value (lowest threshold value) was detected on Day
1 post-surgery and it was of a similar magnitude in both SNI
variants (Figure 1A). However, behavioral discrepancies emerged
over time. The Sural-SNI animals maintained strong mechan-
ical allodynia throughout the entire observation period of 85
days (Figure 1A, dark blue line), consistent with previous reports
(Decosterd and Woolf, 2000; Suter et al., 2003); however, the
Tibial-SNI animals started to recover from mechanical allodynia
at about 2 weeks post-surgery, and displayed almost full recovery
by day 40 post-surgery (Figure 1A, dark green line) (Recio-Pinto
et al., 2012). The naïve and sham operated animals, showed no
significant decrease in the threshold for mechanical allodynia
(Figure 1A, black and purple lines, respectively). Measurements
in the contralateral paws were comparable for all the groups
(Figure 1A, corresponding light color lines).
We found that the Sural-SNI animals developed cold allody-
nia (evidenced by an increase in duration of paw withdrawal)
as previously reported (Decosterd and Woolf, 2000), while the
Tibial-SNI animals never developed cold allodynia. In Sural-SNI
animals the onset of mechanical allodynia was faster than the
onset of cold allodynia, and mechanical allodynia reached its
peak at an earlier time than cold allodynia (Day 1 vs. Day 20
post-surgery) (Figures 1A,B).
The inter-digital distance in the ipsilateral paw significantly
decreased following both SNI modalities, and the magnitude
of change was not statistically different between Sural-SNI and
Tibial-SNI at Day 16 post-surgery (Figure 1C). By Day 83 post-
surgery, the decrease in inter-digital distance was maintained in
FIGURE 1 | Tibial-SNI and Sural-SNI display differences in their pain
phenotype. (A) Mechanical allodynia measurements in the ipsilateral
(IL) and contralateral (CL) paws of Sural-SNI, Tibial-SNI, Sham and
Naïve rats. Only the Sural-SNI and Tibial-SNI groups showed
responses that were significant different between their IL and CL
paws: +P < 0.001, ∗P < 0.05. In addition, a significant difference was
found in the IL responses between Sural-SNI and Tibial-SNI starting at
Day 28 post-surgery: ∧P < 0.001, #P < 0.01. For Sural-SNI and
Tibial-SNI, the number of rats was n = 10 for Days -8, -2, and -1
pre-surgery, and for Days 1, 6, 8, 13, and 28 post-surgery; n = 7 for
Days 20, 37, 43, 50, and 58 post-surgery; n = 6 for Day 65
post-surgery, n = 4 for days 71, 75 post-surgery, and n = 5 for day 83
post-surgery. For Sham, n = 8 from Day -8 pre-surgery to Day 28
post-surgery, and n = 5 for the rest of the post-surgery days. For
Naïve, n = 3 for all time points. (B) Cold allodynia measurements in
the IL and CL paws of Sural-SNI, Tibial-SNI, Sham and Naïve rats.
The only group that showed significance difference between the IL
and CL responses was the Sural-SNI +P < 0.001. The number of rats
was, n = 4 for Sural-SNI and Sham, and n = 3 for Tibial-SNI and
Naïve. (C) Inter-digital distance measurements in the IL and CL paws.
Values were normalized to the mean value observed in the Sham-CL
paw. Significant difference between the indicated groups: +P < 0.001,
#P < 0.01. The number of rats for Day 16 post-surgery were: n = 9
for Sham and Sural-SNI, and n = 8 for Tibial-SNI; for Day 83
post-surgery: n = 6 for all groups. For (A–C): One-Way ANOVA
P < 0.0001; Bonferroni’s Multiple comparison Post-test. (D) Animal’s
weight gain was comparable between Sham+Naive, Sural-SNI, and
Tibial-SNI animals. The number of rats was n = 6 for all groups.
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the Sural-SNI, but it was resolved in Tibial-SNI (Figure 1C).
Animals in all the groups showed comparable increases in weight
over time (Figure 1D) indicating that the surgery did not limit
the animals’ access to and interest in food. In both SNI modali-
ties primary sensory neurons of various sizes are damaged in L4-
and L5-DRG, but not in L3-DRG; however a larger proportion is
damaged in Sural-SNI than in Tibial SNI (Figure 2).
CHANGES IN microRNA EXPRESSION IN DRG FOLLOWING SNI
Since the Sural-SNI and Tibial-SNI models involve damage to
the sciatic nerve, but only the former develops chronic pain, we
used this behavioral difference to identify miRs for which their
dysregulation within the DRG correlated with the development
of chronic pain following a peripheral nerve injury. The sensory
innervation of the rat hind paw involves fibers from the sciatic
and saphenous nerves. The allodynia that develops from cutting
some of the sciatic nerve branches is evoked by stimulation of the
nerve terminals from the spared sciatic nerve branches as well
as from the saphenous nerve that becomes hyperexcitable as a
result of interactions with the injured fibers (Kingery and Vallin,
1989; Kingery et al., 1993; Ro and Jacobs, 1993; Attal et al., 1994;
Tal and Bennett, 1994; Guilbaud et al., 1995; Sotgiu and Biella,
1997; Smith et al., 2013). In rat, the sensory neurons of the saphe-
nous nerve are located in the L3-DRG and for the sciatic nerve
mostly in the L4- and L5-DRG. Hence, we isolated total RNA
from individual L3-DRG, L4-DRG and L5-DRG (ipsilateral and
contralateral) to be used for miR analysis.
To identify the miRs that were differentially dysregulated
between Tibial-SNI and Sural-SNI, we first performed 12
microarrays in a limited number of samples (in four individual
DRG per group: Sham, Tibial-SNI and Sural-SNI; two L3-DRG
and two L4-DRG). Then, miRs identified as having differential
expression were corroborated with real time qRT-PCR in RNA
isolated from individual DRG (L3, L4, and L5) derived from 4
rats per group (groups: Sham, Sural-SNI and TIbial-SNI).
DRG were isolated at Day 23 following the injury since this
time point was associated with 50% recovery in mechanical allo-
dynia in Tibial-SNI (Figure 1A). We postulated that at Day 23
changes were occurring which allow for recovery in Tibial-SNI.
Some of these changes may be transitory, such that they may
be turned off upon reaching maximal recovery (in Tibial-SNI).
Hence, by selecting Day 23, we are increasing the probability
of detecting not only the changes that may contribute to the
development of chronic neuropathic pain in Sural-SNI, but also
changes that may contribute to the recovery from post-nerve
injury pain in Tibial-SNI. Moreover, by using DRG we are con-
centrating on measuring the changes that occur in the sensory
neurons. The microarray used had probes for 380 endogenous
miRs; of these, about 190 were detected in DRG. Comparison
between the two injury models reveals that only nine miRs
were differentially dysregulated between Sural and TIbial-SNI
(Figure 3A). The simultaneous analysis of Sural-SNI vs. Tibial-
SNI refines themiRs that are potentially relevant to the differences
in the pain phenotype of both SNI variants. Of the nine differen-
tially regulated miRs, in Tibial-SNI seven showed an increase and
one a decrease, while in Sural-SNI five showed a decrease and two
an increase. When using qPCR we confirmed that seven out of the
nine miRs identified with the microarrays displayed significant
FIGURE 2 | Labeling of injured neurons. Images of DRG sections from
ipsilateral L3-, L4-, and L5-DRG derived from Sural-SNI (A–C) and Tibial-SNI
(D–F). Sensory neurons are labeled with Nissl (green) and injured sensory
neurons are labeled with Dil (red). Sensory neurons of various sizes are
damaged in L4- and L5-DRG, but not in L3-DRG. A larger proportion of injured
primary sensory neurons are observed in Sural-SNI than in Tibial SNI. White
boxes in the bottom left panels of (B,C,E,F) correspond to the expanded area
shown in their corresponding bottom right panels. Scale bars = 100μm.
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FIGURE 3 | In ipsilateral DRG seven miRs are differentially regulated
between Sural-SNI and Tibial-SNI. (A) By using a microarray chip
containing probes for detecting 375 miRs, we found that only nine miRs
were differentially regulated in IL DRG between Sural-SNI and Tibial-SNI at
Day 23. Ct values were <30.60 for miR-133b, <27.78 for miR-145, <27.66 for
miR-193b, <30.19 for miR-143, <33.69 for miR-335, <23.42 for miR-191,
<37.89 for miR-130a, <36.00 for miR-325, <32.04 for miR-1. Reference miRs
were: MammU6-4395470 (Ct values < 19.30), snoRNA135-4380912 (Ct
values < 33.98), and U87-4386735 (Ct values < 28.32). The n value was four
DRG (two L3 and two L4). For each SNI-group, the mean value from four
individual DRG (two L3-DRG and two L4 DRG) were used. (B,C) By using
qPCR it was confirmed that seven out of the initially identified nine miRs (in
A) were differentially regulated in IL DRG between Sural-SNI and Tibial SNI at
Day 23, whether using the data from L3 and L4 (B) or the data from L3, L4,
and L5 (C); n = 4 rats. (D) By using qPCR the levels of the identified miRs
were measured at Day 7; n = 3 rats. (B–D) The Ct values were <29.94 for
miR-133b, <24.67 for miR-145, <27.42 for miR-193b, <34.17 for miR-143,
<30.74 for miR-335, < 23.90 for miR-191, <32.17 for miR-130a, <32.62 for
miR-325, <30.61 for miR-1. Reference miRs were: snoRNA135-4380912 (Ct
values < 30.94) and U87-4386735 (Ct values < 25.16). For each rat, the mean
value between their DRG (L3, L4, and L5) was used. In (A–D), the “fold
change” (2−CT) was obtained by comparing the experimental sample
(Sural-SNI or Tibial-SNI CT) vs. the sham sample (Sham CT). Significance
between the Tibial-SNI and Sural-SNI: @P < 0.005, ∗P < 0.02, +P < 0.05,
∧P < 0.07; #P < 0.09, Unpaired t-test, one-tailed. Hence the Sham value will
be set to “0” (log2(fold change)=0) (in this and in Figures 4, 5).
differential regulation between Tibial- and Sural-SNI whether
when using data from L3 and L4 (Figure 3B) or when using
data from L3, L4 and L5 (Figure 3C). In both the microarrays
(Figure 3A) and qPCR (Figures 3B,C) seven miRs (miR-133b,
miR-145, miR-193b, miR-143, miR-335-5p, miR-191, miR-1) had
a significantly higher level of expression in Tibial-SNI than in
Sural-SNI. The results for the other two miRs (miR-130a and
miR-325) observed in the microarray were not confirmed with
qPCR. This was the case even when using the same RNA sam-
ples. We used two different batches of primers for qPCR and the
results were the same. We do not understand this discrepancy,
however, since they did not show a significant difference between
Tibial-SNI and Sural-SNI when using qPCR we did not consider
them in our subsequent analysis. At Day 7, the expression of
eight of the nine miRs showed no statistical difference between
Sural-SNI and Tibial-SNI (Figure 3D), at a time when both SNI
modalities display the same level of mechanical allodynia. At Day
7, the only miR that displayed a difference (between Sural-SNI
and Tibial-SNI) was miR-143, which showed a downregulation in
Tibial-SNI. At Day 23 miR-143 shows an upregulation in Tibial-
SNI. The sequence of five of the seven identified miRs is identical
between mice, rats and humans. The two exceptions, miR-1 and
miR-193b are identical between mice and humans. In rats miR-1
differs in one nucleotide, and miR-193b is 3 nucleotides shorter
(Supplement 2).
We further analyzed the data by plotting the levels of expres-
sion of these miRs in each DRG (Figure 4). Of the three DRG
examined, L4-DRG had the largest magnitude of differential
regulation of these miRs between Tibial-SNI and Sural-SNI
(Figure 4B). In L4-DRG not only was there an increase in the
expression of these seven miRs in Tibial-SNI, but there was also a
decrease in four of these miRs in Sural-SNI (Figure 4B). L3-DRG,
which contains the somata of the uninjured saphenous nerve
fibers, also showed differential regulation between the two SNI
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FIGURE 4 | The level of miR differential regulation is highest in
ipsilateral L4-DRG as compared to ipsilateral L3-DRG and L5-DRG.
For comparison purposes the expression level of the seven identified
miRs is shown when the data of the three IL DRG (L3, L4, and L5) was
pooled together (A); and for the individual IL DRG: (B) L3-DRG; (C)
L4-DRG; and (D) L5-DRG. The data in (A) corresponds to that shown in
Figure 3B, except that only the seven miRs with statistical significant
difference between Sural-SNI IL vs. Tibial-SNI IL are shown In all cases
n = 4 rats. ∗P < 0.02, +P < 0.05, #P < 0.09 between Sural-SNI IL vs.
Tibial-SNI IL, Unpaired t-test, one-tailed.
variants, but only three of these miRs (miR-133b, miR-145, miR-
143) were significantly different. In L5-DRG, although a similar
tendency was observed (higher expression levels in Tibial-SNI
than in Sural-SNI), none of the seven miRs, showed a significant
differential regulation between Tibial-SNI and Sural-SNI.
We also examined the expression of these seven miRs in the
contralateral DRG. We found that as compared to sham, the
expression of these miRs was also affected in the contralateral
DRG (Figure 5). However, except for miR-1, the regulation in
the contralateral DRG was comparable in the two SNI variants.
A similar pattern was observed for contralateral L5-DRG and
contralateral L3-DRG (data not shown).
To investigate the pain relevance of the seven identified miRs
we checked their predicted mRNA targets using TargetScan and
Miranda software. Since alterations in neuronal excitability of
both injured (Wall and Gutnick, 1974a,b; Wall and Devor, 1983;
Tal and Eliav, 1996; Liu et al., 1999, 2000a,b) and uninjured
neurons (Ali et al., 1999; Wu et al., 2001, 2002; Gold et al.,
2003; Smith et al., 2013) are believed to contribute to the ini-
tiation and maintenance of chronic neuropathic pain following
peripheral nerve injury, we selected mRNA targets that encode
for ion channels known to contribute and modulate neuronal
excitability and some that have been already postulated to con-
tribute to chronic neuropathic pain. This was done to investigate
how the observed changes in miR expression could potentially
affect neuronal excitability following injury. Figure 6 shows some
of these mRNA targets, the miR name is color-coded to indi-
cate whether its expression did not change (black), decreased
(blue), or increased (red), in DRG derived from either the Sural-
SNI (top row) or Tibial-SNI (bottom row). Pooled data and
that for L4-DRG (Figures 4A,C) were used. Based on knock-
out studies, the predicted mRNA targets (shown in light brown)
have already been associated with hypersensitivity in various pain
models (http://www.jbldesign.com/jmogil/enter.html) (Lacroix-
Fralish et al., 2007), including some in which alterations in
mechanical and/or cold allodynia were found. These include
the voltage dependent sodium channel SCN9A (Nassar et al.,
2004), the sodium channel beta 2 subunit (SCN2B) (Pertin et al.,
2005; Lopez-Santiago et al., 2006), the voltage-dependent cal-
cium channels T-type (Choi et al., 2007; Lee et al., 2009; Chen
et al., 2010), N-type (Hatakeyama et al., 2001; Kim et al., 2001;
Saegusa et al., 2001) and P/Q-type (Luvisetto et al., 2006), the
pacemaker channels HCN1 (Momin et al., 2008) and HCN2
(Emery et al., 2011), the ligand-gated, non-selective cation chan-
nel TRPV1 (Caterina et al., 2000; Wang et al., 2008) and the
transient receptor potential channel TRPM8 (Bautista et al., 2007;
Dhaka et al., 2007; Gentry et al., 2010; Knowlton et al., 2010).
Some of these targets such as the voltage-dependent calcium
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FIGURE 5 | Nerve injury also evokes changes in miR expression in the
contralateral DRG. The expression level of the seven identified miRs is
shown for the ipsilateral L4-DRG (IL) and from the contralateral L4-DRG (CL)
derived from Sural-SNI and Tibial-SNI. The seven miRs showed differential
regulation in the ipsilateral L4-DRG between the two SNI variants (as
shown in Figure 4C). Compared to values of DRG derived from Sham
animals (which in the graph corresponds to 0) these seven miRs also
showed changes in regulation in the contralateral L4-DRG. These changes
were comparable in the two SNI variants, only being significantly different
for miR-1. Significant difference between Sural-SNI L vs. Tibial SNI-L or
between Sural-SNI CL vs. Tibial-SNI CL: ∗P < 0.02, +P < 0.05, #P < 0.09,
Unpaired t-test, one-tailed.
channels T-type (Latham et al., 2009; Lee et al., 2014) and N-type
(Shao et al., 2012; Adams and Berecki, 2013), and the TRPM8
channel (Knowlton et al., 2011) were originally identified using
pharmacological studies. In studies measuring protein expres-
sion levels and using pharmacological agents proteins encoded
by other of the identified mRNA targets, such as the voltage-
dependent sodium channels SCN8A (Deuis et al., 2013), the
auxiliary α2δ-1 subunit (Moore et al., 2009, 2011; Bauer et al.,
2010) and β(3) subunit (Li et al., 2012) of voltage-gated calcium
channels, have also been implicated in the development of either
mechanical or cold allodynia.
Based on our miR results, the translation of these mRNAs
would be predicted to increase in the Sural-SNI due to the
decreased expression of four of the identified miRs and would
be predicted to decrease in the Tibial-SNI due to the increased
expression of all of the seven identified miRs.
DISCUSSION
In this study we describe an experimental approach to increase
the probability of detecting biological changes that contribute to
the development of chronic neuropathic pain following a periph-
eral nerve injury. The approach consisted in using the Sural-SNI
and Tibial-SNI, because both models involved sciatic nerve dam-
age but displayed distinct pain phenotypes. Both SNI modalities
displayed the same level of mechanical allodynia and functional
disruption as ascertained by the reduction of inter-digital distance
in the acute and sub-chronic post-operative period. However,
over time, only the Tibial-SNI recovered in both of these phe-
notypes. Moreover, only the Sural-SNI developed chronic cold
allodynia. By using this approach we identified seven miRs within
the DRG that are likely transducers of these two distinct pain
phenotypes, in part, via regulation of neuronal excitability and
neuronal sprouting.
Peripheral nerve injury alters the expression of hundreds of
proteins in DRG (Hokfelt et al., 1994; Araki et al., 2001; Bonilla
et al., 2002; Costigan et al., 2002; Wang et al., 2002; Xiao et al.,
2002; Jimenez et al., 2005; Nilsson et al., 2005; Komori et al.,
2007; Stam et al., 2007). The differences in protein expression
between models (Niederberger et al., 2008), in part, reflect that
not all of the injury-induced protein changes necessarily lead to
neuropathic pain. The Sural-SNI model is one of two models
that involve partial sciatic nerve transection in which blocking
the nerve impulses before and during a week following the injury
does not eliminate the development of chronic neuropathic pain
(Dougherty et al., 1992; Suter et al., 2003, 2011; Yang et al., 2014).
This phenomenon resembles the outcome of a significant number
of surgical patients for whom control of acute post-surgical pain
does not prevent the development of chronic neuropathic pain
(Perkins and Kehlet, 2000). At least in this specific patient popu-
lation, the development of chronic pain involves dysregulation of
multiple proteins that have not yet been fully identified.
Because a single miR can affect the expression of many pro-
teins (Klein et al., 2005) we used the two SNI variants to increase
the probability of identifying pain relevant miRs in the DRG.
We found that only a few miRs were differentially regulated in
DRG derived from Tibial-SNI and Sural-SNI. The relatively low
number of miRs that were differentially regulated was expected,
since by using the two SNI modalities the probability of including
injury-induced changes in miR expression that did not contribute
to the development of chronic pain was most likely reduced.
The allodynia that develops following the SNI injury (ligation
and cut of two sciatic nerve branches with removal of 2–3mm of
nerve stump) is evoked by stimulation of the spared nerve termi-
nals that become hyperexcitable as a result of interactions with the
injured fibers, as has been shown for the spared-sural branch in
Sural-SNI (Smith et al., 2013). Moreover, functional interactions
between the saphenous nerve and the damaged sciatic nerve con-
tribute to pain disorders following sciatic nerve injury (Kingery
and Vallin, 1989; Kingery et al., 1993; Ro and Jacobs, 1993; Attal
et al., 1994; Tal and Bennett, 1994; Guilbaud et al., 1995; Sotgiu
and Biella, 1997). Evoked (mechanical, cold) injury-induced neu-
ropathic pain reflects changes in primary sensory neurons, even
if other components such as motor and sympathetic are playing
a role. Differences in injury-evoked inflammation could also be
contributing to our results, because inflammation not only can
lead to neuropathic pain, but also to changes in miR expression in
DRG (Sakai and Suzuki, 2014). Based on our findings, it appears
that depending on the proportion and/or type of damaged pri-
mary sensory neurons, the damaged neurons and those closely
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FIGURE 6 | Predicted mRNA targets for the identified miRs.
TargetScan and Miranda software was used to identify potential mRNA
targets for the identified miRs. The list of potential mRNA targets was
filtered: by selecting those that encode for ion channels. Here we
show those encoding for voltage-dependent sodium channels: α
(SCNXA) and β (SCNXB) subunits; voltage-dependent calcium channels:
α (CACNA1X), β (CaCh-βX), γ (CaCh- γX), γ2δX (CaCh-γ2δX), and δ
(CaCh-δX) subunits. The pacemaker channels (HCNX), the ligand-gated,
non-selective cation channel TRPV1, the transient receptor potential
channel TRPM8, and cannabinoid receptors (CNRX). “X” Stands for
various numbers as indicated in the figure. We then used the http://
www.jbldesign.com/jmogil/enter.html (Lacroix-Fralish et al., 2007) to find
which mRNA targets have been associated with neuronal
hypersensitivity by using knockout studies.
interacting with them undergo changes in miR expression that
may either limit the development of chronic neuropathic pain as
in Tibial-SNI or promote the development of chronic neuropathic
pain as in Sural-SNI.
Since injury-induced neuronal hyperexcitability contributes to
the initiation and maintenance of chronic neuropathic pain fol-
lowing a peripheral nerve injury (Wall and Gutnick, 1974a,b;
Wall and Devor, 1983; Tal and Eliav, 1996; Ali et al., 1999; Liu
et al., 1999, 2000a,b; Wu et al., 2001, 2002; Gold et al., 2003),
we inspected how the observed changes in miR expression could
potentially affect the expression of the predicted mRNA targets
that encode for ion channels. This analysis indicated that the
translation of various ion channels, including some that have
already been found to contribute to neuronal hyperexcitability
and neuropathic pain (see Results), would be expected to increase
in Sural-SNI primary sensory neurons due to the decreased
expression of at least four miRs (miR-133b-3p, miR143, miR-
335-5p, miR-1). On the other hand, the translation of these ion
channels would be predicted to decrease in the Tibial-SNI pri-
mary sensory neurons due to the increase in expression of all
seven identified miRs (miR-133b, miR-145, miR-193b, miR-143,
miR-335-5p, miR-191, miR-1). At Day 7 the two SNI modalities
display the same high level of mechanical allodynia. Interestingly,
at Day 7 the expression of these miRs in both SNI modalities is
similar and would be expected to increase excitability since most
of miRs show an expression level lower than that displayed by
Sham controls. This analysis supports the view that the down-
regulation of four of the identified miRs appears to orchestrate
the development of chronic neuropathic pain in Sural-SNI while
the up-regulation of all seven of the identified miRs appear to
orchestrate the recovery from post-nerve injury induced pain in
Tibial-SNI.
We found that as compared to sham, the expression of these
miRs was also affected in the contralateral DRG (Figure 5). Except
for miR-1, the regulation in the contralateral DRG was compa-
rable in the two SNI variants, and more closely resembles the
expression pattern in the ipsilateral DRG of Tibial-SNI. This
expression pattern in the contralateral DRG correlates with the
observed lack of allodynia and with the predicted lack of an
increase in excitability in the contralateral paw. Hence, because
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miR changes are occurring in the contralateral DRG, which may
reflect a compensatory or protective effect, using the contralat-
eral DRG as the control should be avoided, even when using
peripheral nerve injury models in which neuropathic pain does
not develop in the contralateral paw.
Of the seven miRs identified, miR-145 is consistently altered
in two other sciatic nerve injury models. Following complete
sciatic nerve transection, miR-145 is decreased in DRG (Zhang
et al., 2011; Zhou et al., 2011) and nerve stump (Yu et al., 2012).
Sciatic nerve transection results in chronic mechanical hyperal-
gesia and autotomy (Kingery and Vallin, 1989; Persson et al.,
2009b). Following sciatic nerve crush, miR-145 is decreased in
the nerve stump (Viader et al., 2011) at a time period in which
animals display mechanical and cold allodynia (Tamaddonfard
et al., 2014). In our dual injury model, the Tibial-SNI animals,
but not the Sural-SNI animals, recovered from post-injury pain
and showed an increase inmiR-145. Taken together, an increase in
miR-145 correlates with recovery from post-nerve injury induced
pain, while a lack of an increase (Sural-SNI) or decrease (sci-
atic nerve transection, sciatic nerve crush) of miR-145 correlates
with development of chronic pain following a peripheral nerve
injury. Enhancement of miR-145 reduces neurite outgrowth in
cultured DRG sensory neurons (Zhang et al., 2011). Hence, it
appears that decreasing miR-145 in primary sensory neurons
contributes to the development of chronic pain by enhancing
the expression of ion channels known to contribute to neuronal
hyperexcitability and possibly by promoting non-specific sprout-
ing following a peripheral nerve injury. The opposite will be the
case in Tibial-SNI in which there is an increase in miR-145.
Another miR that has been studied in reference to neuro-
pathic pain is miR-1. In DRG, the level of miR-1 was increased
following axotomy while it was decreased following partial sci-
atic nerve ligation (Kusuda et al., 2011). Enhancement of miR-1
reduces neurite outgrowth of cultured DRG sensory neurons
(Bastian et al., 2011). Based on our findings we propose that
the observed decrease of miR-1 in partial nerve ligation (Kusuda
et al., 2011) and Sural-SNI (this study) might contribute to the
development of chronic pain by enhancing excitability and by
promoting aberrant sprouting of nerve branches. In contrast,
the increase in miR-1 following axotomy (Kusuda et al., 2011)
and Tibial-SNI (this study) could actually be a compensatory
response to limit the level of neuronal hyperexcitability and the
level of aberrant sprouting, at least during the first weeks fol-
lowing axotomy. These may contribute to recovery in Tibial-SNI.
Consistent with this view the overexpression of miR-1 in car-
diac myocytes slows conduction and depolarizes these cells partly
through post-transcriptional repression of GJA1 (which encodes
for connexin-43) (Yang et al., 2007). Moreover, an increase in
connexin-43 expression in trigeminal DRG appears to contribute
to pain development following nerve injury (Ohara et al., 2008).
In Sural-SNI, the protein level of Nav1.7 channel has been found
to be increased (Laedermann et al., 2013) despite a decrease in
Nav1.7 mRNA (Berta et al., 2008; Laedermann et al., 2014). These
apparent contradictory results could be explained by our obser-
vation that miR-1 is decreased. The decrease in miR-1 would
accelerate protein translation compensating for the decrease in
mRNA.
The pacemaker channels HCN1 and HCN2 contribute to
the generation of ectopic firing (Jiang et al., 2008) and neuro-
pathic pain (Momin et al., 2008; Wan, 2008; Emery et al., 2011)
following sciatic nerve injury. We found that several of the iden-
tified miRs that were decreased in Sural-SNI and increased in
Tibial-SNI are predicted to target mRNA encoding for these chan-
nels (Figure 5). Decrease of these miRs could account for the
previously observed increase in pacemaker channels and hyper-
excitability of primary sensory neurons following sciatic nerve
injury.
Peripheral nerve injury changes neuronal activity not only
on primary sensory neurons but also in ascending and descend-
ing spinothalamic and spinomesencephalic tract neurons (Martin
and Ewan, 2008; Lavertu et al., 2014; Salter, 2014). Moreover,
whether initiated by a peripheral or a central injury, chronic
neuropathic pain ultimately becomes centralized through alter-
ation (synapses, morphology, receptors, channels, excitability,
and function) of various brain systems; the extent of these
changes varies between chronic pain conditions. For example, the
resulting altered sensation, such as allodynia and hyperalgesia,
involve changes in the primary sensory and motor cortices, the
thalamus and posterior Insula (Moisset and Bouhassira, 2007).
Hence targeting primary sensory neurons may be mostly helpful
at stages or in conditions in which their altered function is con-
tributing to the initiation or to the continuousmaintenance of the
central alterations that result in chronic neuropathic pain.
Peripheral nerve injury not only produces changes in miR
expression at the DRG, but also at the spinal cord (Genda et al.,
2013) and brain (Arai et al., 2013; Hori et al., 2013). Hence, pain
relevant miRs at any sensory level would potentially provide addi-
tional tools for the treatment of chronic neuropathic pain. With
respect to the Sural-SNI model, an increase in miR-124a at the
spinal cord leads to a decrease in mechanical allodynia (Willemen
et al., 2012). Moreover, depending on the nerve injury type the
relevant miRs may differ. For example, in the spinal nerve ligation
model, intrathetal injections of miR-21 (Sakai and Suzuki, 2013),
miR-103 (Favereaux et al., 2011), miR-183 (Lin et al., 2014) or
of miR-195 inhibitor (Shi et al., 2013), and injection of miR-7a
into the L5-DRG (Sakai et al., 2013) attenuate pain. In a bone
cancer model, intrathetal injections of miR-1-inhibitor or miR-
34c-5p-inhibitor, respectively produce a mild or a strong decrease
in mechanical hypersentitivity (Bali et al., 2013). In spinal cord
injury, inthathecal injections of miR-23b attenuate mechanical
and thermal pain (Im et al., 2012). In inflammatory pain models,
intravenous delivery (Kynast et al., 2013) or intrathecal delivery
(Willemen et al., 2012) of miR-124a ameliorates pain.
It has been reported that the expression of 19–200 miRs is
altered in DRG following peripheral nerve injuries (Strickland
et al., 2011; Yu et al., 2011a,b; Zhang et al., 2011; Zhou et al.,
2011; Li et al., 2013); such variability has been observed even
when using the same injury model (Yu et al., 2011a,b; Zhang
et al., 2011; Zhou et al., 2011). However, what is most surpris-
ing is the lack of overlap in the identified miRs among studies
(Strickland et al., 2011; Yu et al., 2011a,b; Zhang et al., 2011; Zhou
et al., 2011; Li et al., 2013). Since DRG isolation is time and labor
intensive we perfused the animals with cold ACSF to reduce RNA
degradation and processing during tissue isolation and to remove
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blood-derived miR contaminants. As far as we can tell, none of
the previously published studies referred to above used perfusion
prior to DRG isolation. Therefore, the lack of overlap in altered
miRs, particularly when using the same injury model may be a
consequence of methodological issues ranging from blood miR
contaminants and metabolic shock-evoked RNA processing, to
tissue isolation time.
Six of the seven miRs that we identified were within the list
of 48 miRs altered in the sciatic nerve stump following a sciatic
nerve crush (Viader et al., 2011). Isolation of the nerve stump
is much faster, and hence, pre-cooling prior to tissue isolation
may not be as critical for RNA stability/processing as when isolat-
ing DRG. Local protein synthesis also occurs in axons (Murashov
et al., 2007) and neuromas (mass of nerve tissue resulting from
abnormal regrowth of the stumps of severed nerves) (Huang
et al., 2008) and miRs at these locations (Natera-Naranjo et al.,
2010; Kaplan et al., 2013) are likely to also regulate local pro-
tein synthesis. Therefore, it is not surprising that six of the miRs
that we identified to be differentially regulated in DRG were also
found to be altered in the sciatic nerve following a sciatic nerve
crush (Viader et al., 2011). By using the rationale from our dual
SNI variants we interpret that the decrease in expression of four
miRs (miR-133b-3p, miR-145, miR-143, and miR-1) contributes
to pain while the increase in expression of two miRs (miR-
193b-3p and miR-191-5p) limits the level of pain that develops
following a sciatic nerve crush. In the array, additional potential
differentially dysregulated miRs were detected, that similarly dis-
played an apparent higher level of expression in Tibial-SNI than
in Sural-SNI (Supplement 1). However, based on their predicted
targets the ones we further corroborated with qPCR where those
targeting multiple ion channels (Figure 6).
There are several limitations in the present study, one being
that the predicted mRNA targets were not confirmed and this
will require both mRNA measurements and functional studies.
Obviously the selected mRNA (Figure 5) would not be the only
pain-relevant mRNA targets. In fact, we expect that the effect
of the identified miRs on many more mRNA targets would be
required to underlie the processes leading to the different pain
phenotypes. Our goal was to identify likely pain-relevant miRs by
using the two SNI models, and to validate their pain relevance
by analyzing how their expression changes would affect neuronal
excitability. By comparing the two SNI modalities, rather than
Sham vs. injury, we are increasing the probability of detectingmiR
changes that involve aspects of neuronal processes (excitability,
protein expression, regeneration) that contribute to their different
pain phenotype. Measurements are needed to determine which
of the observed changes in miR expression at Day 23 are transi-
tory and which ones are sustained. Additional studies are required
to investigate whether manipulating the expression of the identi-
fied miRs in primary sensory neurons can prevent or ameliorate
sustained neuropathic pain following peripheral nerves injury.
In this study we first described behavioral differences in the
two SNI variants, and how these can potentially be used to iden-
tify peripheral-nerve injury induced changes (molecular, func-
tional, or structural) at any level of the pain-sensory pathways
(DRG, spinal cord, brain) that correlate with the development
of neuropathic pain. Second, we described the simultaneous
use of these two models to identify pain relevant miRs in the
DRG; and by doing so we identified seven miRs that are likely
transducers of these two pain phenotypes. Finally, to validate
our approach, the analysis focused on interpreting how changes
in the identified miRs could contribute to neuronal hyperex-
citability. We also discussed how previously published results
can be interpreted in light of our findings using the dual model
approach. In summary, the data analysis supports the view
that the down-regulation of four miRs (miR-133b, miR-143,
miR-335-5p, miR-1) appears to orchestrate the development of
chronic neuropathic pain in Sural-SNI while the up-regulation
of seven miRs (miR-133b, miR-145, miR-193b, miR-143, miR-
335-5p, miR-191, miR-1) appear to orchestrate the recovery from
post-nerve injury induced pain in Tibial-SNI.
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